vs
Acadia Healthcare Company, Inc.（ACHC）とSCANSOURCE, INC.（SCSC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Acadia Healthcare Company, Inc.の直近四半期売上が大きい（$821.5M vs $766.5M、SCANSOURCE, INC.の約1.1倍）。SCANSOURCE, INC.の純利益率が高く（2.2% vs -143.3%、差は145.5%）。Acadia Healthcare Company, Inc.の前年同期比売上増加率が高い（6.1% vs 2.5%）。SCANSOURCE, INC.の直近四半期フリーキャッシュフローが多い（$28.9M vs $-179.5M）。過去8四半期でAcadia Healthcare Company, Inc.の売上複合成長率が高い（3.4% vs 0.9%）
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
ScanSource社は世界有数の専門技術流通企業で、POSシステム、バーコードスキャナー、サイバーセキュリティ製品、クラウドサービス、通信ソリューションなどを取り扱い、北米・中南米・欧州の付加価値販売業者、サービスプロバイダー、企業顧客向けに事業を展開し、小売、医療、産業、公共部門を主な対象分野としています。
ACHC vs SCSC — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $821.5M | $766.5M |
| 純利益 | $-1.2B | $16.5M |
| 粗利率 | — | 13.4% |
| 営業利益率 | -142.4% | 2.3% |
| 純利益率 | -143.3% | 2.2% |
| 売上前年比 | 6.1% | 2.5% |
| 純利益前年比 | -3710.4% | -3.3% |
| EPS（希薄化後） | $-12.98 | $0.75 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $821.5M | $766.5M | ||
| Q3 25 | $851.6M | $739.6M | ||
| Q2 25 | $869.2M | $812.9M | ||
| Q1 25 | $770.5M | $704.8M | ||
| Q4 24 | $774.2M | $747.5M | ||
| Q3 24 | $815.6M | $775.6M | ||
| Q2 24 | $796.0M | $746.1M | ||
| Q1 24 | $768.1M | $752.6M |
| Q4 25 | $-1.2B | $16.5M | ||
| Q3 25 | $36.2M | $19.9M | ||
| Q2 25 | $30.1M | $20.1M | ||
| Q1 25 | $8.4M | $17.4M | ||
| Q4 24 | $32.6M | $17.1M | ||
| Q3 24 | $68.1M | $17.0M | ||
| Q2 24 | $78.5M | $16.1M | ||
| Q1 24 | $76.4M | $12.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | -142.4% | 2.3% | ||
| Q3 25 | 4.7% | 3.5% | ||
| Q2 25 | 5.8% | 3.3% | ||
| Q1 25 | 1.7% | 3.2% | ||
| Q4 24 | 4.9% | 2.5% | ||
| Q3 24 | 12.1% | 2.3% | ||
| Q2 24 | 13.4% | 2.9% | ||
| Q1 24 | 12.9% | 2.3% |
| Q4 25 | -143.3% | 2.2% | ||
| Q3 25 | 4.3% | 2.7% | ||
| Q2 25 | 3.5% | 2.5% | ||
| Q1 25 | 1.1% | 2.5% | ||
| Q4 24 | 4.2% | 2.3% | ||
| Q3 24 | 8.4% | 2.2% | ||
| Q2 24 | 9.9% | 2.2% | ||
| Q1 24 | 9.9% | 1.7% |
| Q4 25 | $-12.98 | $0.75 | ||
| Q3 25 | $0.40 | $0.89 | ||
| Q2 25 | $0.33 | $0.87 | ||
| Q1 25 | $0.09 | $0.74 | ||
| Q4 24 | $0.36 | $0.70 | ||
| Q3 24 | $0.74 | $0.69 | ||
| Q2 24 | $0.85 | $0.66 | ||
| Q1 24 | $0.83 | $0.50 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $133.2M | $83.5M |
| 総負債低いほど良い | $2.5B | — |
| 株主資本純資産 | $1.9B | $910.9M |
| 総資産 | $5.5B | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | 1.28× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $133.2M | $83.5M | ||
| Q3 25 | $118.7M | $124.9M | ||
| Q2 25 | $131.4M | $126.2M | ||
| Q1 25 | $91.2M | $146.3M | ||
| Q4 24 | $76.3M | $110.5M | ||
| Q3 24 | $82.1M | $145.0M | ||
| Q2 24 | $77.2M | $185.5M | ||
| Q1 24 | $77.3M | $159.1M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.9B | — |
| Q4 25 | $1.9B | $910.9M | ||
| Q3 25 | $3.1B | $914.0M | ||
| Q2 25 | $3.1B | $906.4M | ||
| Q1 25 | $3.0B | $901.7M | ||
| Q4 24 | $3.1B | $900.7M | ||
| Q3 24 | $3.0B | $920.9M | ||
| Q2 24 | $3.0B | $924.3M | ||
| Q1 24 | $2.9B | $944.1M |
| Q4 25 | $5.5B | $1.7B | ||
| Q3 25 | $6.4B | $1.7B | ||
| Q2 25 | $6.3B | $1.8B | ||
| Q1 25 | $6.1B | $1.7B | ||
| Q4 24 | $6.0B | $1.7B | ||
| Q3 24 | $5.9B | $1.8B | ||
| Q2 24 | $5.7B | $1.8B | ||
| Q1 24 | $5.5B | $1.8B |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.65× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-86.3M | $30.8M |
| フリーキャッシュフロー営業CF - 設備投資 | $-179.5M | $28.9M |
| FCFマージンFCF / 売上 | -21.8% | 3.8% |
| 設備投資強度設備投資 / 売上 | 11.3% | 0.3% |
| キャッシュ転換率営業CF / 純利益 | — | 1.87× |
| 直近12ヶ月FCF直近4四半期 | $-439.9M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-86.3M | $30.8M | ||
| Q3 25 | $73.2M | $23.2M | ||
| Q2 25 | $133.5M | — | ||
| Q1 25 | $11.5M | $66.1M | ||
| Q4 24 | $116.7M | $-6.2M | ||
| Q3 24 | $163.1M | $44.8M | ||
| Q2 24 | $171.1M | — | ||
| Q1 24 | $-321.3M | $160.2M |
| Q4 25 | $-179.5M | $28.9M | ||
| Q3 25 | $-63.0M | $20.8M | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | $64.6M | ||
| Q4 24 | $-86.8M | $-8.2M | ||
| Q3 24 | $-27.1M | $42.5M | ||
| Q2 24 | $16.9M | — | ||
| Q1 24 | $-463.7M | $157.7M |
| Q4 25 | -21.8% | 3.8% | ||
| Q3 25 | -7.4% | 2.8% | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | 9.2% | ||
| Q4 24 | -11.2% | -1.1% | ||
| Q3 24 | -3.3% | 5.5% | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -60.4% | 21.0% |
| Q4 25 | 11.3% | 0.3% | ||
| Q3 25 | 16.0% | 0.3% | ||
| Q2 25 | 19.3% | 0.3% | ||
| Q1 25 | 22.7% | 0.2% | ||
| Q4 24 | 26.3% | 0.3% | ||
| Q3 24 | 23.3% | 0.3% | ||
| Q2 24 | 19.4% | 0.2% | ||
| Q1 24 | 18.5% | 0.3% |
| Q4 25 | — | 1.87× | ||
| Q3 25 | 2.02× | 1.17× | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | 3.79× | ||
| Q4 24 | 3.58× | -0.36× | ||
| Q3 24 | 2.39× | 2.64× | ||
| Q2 24 | 2.18× | — | ||
| Q1 24 | -4.21× | 12.51× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
